Page 49 - BH-1-2
P. 49

Brain & Heart                                                  RDN guided by novel blood pressure responses




            Table 2. Characteristic parameters of five BP response patterns
                      No.                SBP change , mmHg                         Occurrence time , (s)
                                                 a
                                                                                              b
                              Minimum      Maximum     End‑stimulation  Minimum      Maximum     End‑stimulation
            Type 1    74       3.7±5.0     14.3±8.9       11.6±7.9       16.9±7.7    21.2±11.2      27.0±14.5
            Type 2    47      −14.0±7.1    13.2±7.6        8.3±9.6       14.2±3.5    23.4±9.5       32.3±9.1
            Type 3    50      −16.7±8.4    −1.8±5.9       −3.6±5.6       17.9±6.3    31.1±13.1      40.7±12.7
            Type 4    71       −1.0±2.1     1.3±2.0        0.3±2.2       17.5±6.7    18.3±11.9      24.6±11.3
            Type 5    18      −12.5±7.4    −5.3±5.7       −11.4±7.3     24.9±11.2    16.0±12.9      30.4±14.2
            Notes: Values are mean±SD.  Change of mean SBP compared to the first 10 cardiac cycles prior to electrical stimulation.  Occurrence time interval
                               a
                                                                                         b
            compared to the initiation of the electrical stimulation.
            Abbreviation: SBP: Systolic blood pressure.
            Table 3. Antihypertensive drugs at baseline and follow‑ups  A

                                     Baseline  5 – 7 days  6 – 12
                                                    months
            No. of antihypertensive medications  2.9±1.3  3.0±1.3  2.4±1.2
            ACE-I/ARB                  10     10      7
            Calcium channel blockers   11     10      9
            Beta adrenoceptor-blocking agents  10  10  11
            Diuretic                   7       9      6
            Alpha adrenoceptor-blocking agents  2  2  0
            Notes: Values are mean±SD or n.
            Abbreviations: ACE-I: Angiotensin-converting enzyme inhibitor;
            ARB: Angiotensin receptor blockers.


                                                               B

















                                                               Figure  4. Changes in ambulatory blood pressure and heart rate after
                                                               selective RDN. (A) Consistent decrease of ambulatory blood pressure
                                                               (BP) and heart rate at 5 – 7 days and 6 – 12 months after renal denervation
                                                               (RDN). (B) Mean and standard error of postoperative ambulatory BP
            Figure  3.  Electrical stimulation-induced changes in SBP before and   drop. *P < 0.05 and.  P < 0.001 for comparison between baseline and 5 –
                                                                            #
            after RDN. After renal denervation (RDN), systolic blood pressure   7 days and 6 – 12 months by univariate repeated measurement analysis
            (SBP) elevations during repeated renal stimulation (RNS) were blunted   of variance.
            significantly in sites with type 1 and type 2. *P < 0.05 and #P<0.001 for
            comparison between before and after RDN by paired sample t-test.
                                                               evaluated  the changes  in BP  after  selective  RDN in
            4. Discussion                                      patients with hypertension. We mainly obtained the
                                                               following results: (i) RNS can evoke five types of rapid BP
            This study summarized several types of rapid BP    responses. Biphasic changes (drop before rise) of SBP can
            response patterns caused by electrical stimulation and   be elicited successively at some sites. (ii) ABP and heart


            Volume 1 Issue 2 (2023)                         7                         https://doi.org/10.36922/bh.0384
   44   45   46   47   48   49   50   51   52   53   54